---
title: "CAPS: Phenylephrine 40 mg added to 0.9% Sodium Chloride 250 mL in 250 mL Exce... — FDA announcement Feb 25, 2025 | Is It on Recall"
description: "Due to visible black particulate matter"
url: https://isitonrecall.com/recall/fdapress-bd42b3c8824a1a1a-caps-phenylephrine-40-mg-added-to-0-9-sodium-chloride-250-ml-in-250-ml-excel-bag/
updated: 2026-10-01
site: "Is It on Recall"
language: en
---

[Recall archive](https://isitonrecall.com/archives/) / FDA company announcement

# CAPS: Phenylephrine 40 mg added to 0.9% Sodium Chloride 250 mL in 250 mL Excel Bag — FDA announcement Feb 25, 2025

Published notice; closure not supplied

A company announcement posted by FDA. The listing date can differ from the original announcement date. The absence of a termination marker does not prove the recall is currently ongoing.

Source date Feb 25, 2025. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; [check FSIS directly](https://www.fsis.usda.gov/recalls). [Source coverage and dates](https://isitonrecall.com/sources/).

## What the record says

- **Product**: Phenylephrine 40 mg added to 0.9% Sodium Chloride 250 mL in 250 mL Excel Bag
- **Reason**: Due to visible black particulate matter
- **Classification**: Not supplied
- **Recalling firm**: CAPS
- **Quantity**: Not supplied
- **Agency-reported status**: Company recall announcement
- **Source record identifier**: bd42b3c8824a1a1a

[Open the official record](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/central-admixture-pharmacy-services-caps-issues-nationwide-recall-phenylephrine-40-mg-added-09)

## Lot and product identifiers

| Label field | Details supplied by the agency |
| --- | --- |
| Lot, code or applicability | CAPS drug product is packaged in 0.9% Sodium Chloride 250 mL in 250 mL Excel Bag. The product can be identified by the sample label below, the NDC format for products compounded at Lehigh Valley is “71285-XXXX-X.” The lot number format is “37-XXXXXX.”; NDC \| Product Description \| Lot # \| Expiration Date \| Distribution Dates \| Region Distributed; 71285-6092-1 \| Phenylephrine 40 mg added to 0.9% Sodium Chloride 250 mL in 250 mL Excel Bag \| 37-928390 \| 03MAR2025 \| 17 Dec 2024 \| United States; 71285-6092-1 \| Phenylephrine 40 mg added to 0.9% Sodium Chloride 250 mL in 250 mL Excel Bag \| 37-928796 \| 09MAR2025 \| 26 Dec 2024 \| United States; 71285-6092-1 \| Phenylephrine 40 mg added to 0.9% Sodium Chloride 250 mL in 250 mL Excel Bag \| 37-928839 \| 10MAR2025 \| 03 Jan 2025 – 08 Jan 2025 \| United States |

Match all identifying details in the current notice. A brand name alone is not enough.

## Product tables from the announcement

These identifying details come from the company announcement posted by FDA. Check the current notice for revisions.

**FDA company announcement, table 1**

| NDC | Product Description | Lot # | Expiration Date | Distribution Dates | Region Distributed |
| --- | --- | --- | --- | --- | --- |
| 71285-6092-1 | Phenylephrine 40 mg added to 0.9% Sodium Chloride 250 mL in 250 mL Excel Bag | 37-928390 | 03MAR2025 | 17 Dec 2024 | United States |
| 71285-6092-1 | Phenylephrine 40 mg added to 0.9% Sodium Chloride 250 mL in 250 mL Excel Bag | 37-928796 | 09MAR2025 | 26 Dec 2024 | United States |
| 71285-6092-1 | Phenylephrine 40 mg added to 0.9% Sodium Chloride 250 mL in 250 mL Excel Bag | 37-928839 | 10MAR2025 | 03 Jan 2025 – 08 Jan 2025 | United States |

Announcement retrieved Oct 1, 2026. [Official announcement](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/central-admixture-pharmacy-services-caps-issues-nationwide-recall-phenylephrine-40-mg-added-09).

## Distribution

Not supplied

No US distribution state could be established from this record. Check the official notice.

## Dates in the source

- **Fda listing date**: Feb 25, 2025
- **Company announcement date**: Feb 24, 2025

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

## What to do next

Consumers with questions regarding this recall can contact CAPS by calling 1-844-903-6417. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

[Read the current instructions](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/central-admixture-pharmacy-services-caps-issues-nationwide-recall-phenylephrine-40-mg-added-09)

## Before changing a medicine

Follow urgent instructions in the current official recall notice. Speak to your pharmacist or prescriber before stopping or changing a prescribed medicine.

Talk to your doctor or pharmacist if you have questions or concerns about your medicine. [FDA medication recall guidance](https://www.fda.gov/drugs/drug-recalls/understanding-drug-recalls-what-know-and-what-do)

## Related records

[Medications records](https://isitonrecall.com/category/medications/) [CAPS records](https://isitonrecall.com/brand/caps/)